Amarin Corp Plc (AMRN)

[Biobillionair]

Part two: GSK, Merck, and AZN never saw this coming.

Mochida Pharmaceutical Co., Ltd. (Tokyo, JP) is going to Acquire Amarin.

1) Mochida: Generic EPA Japan
2) Mochida: Generic Pitvastatin Japan
3) Kowa: Livalo/Pitvastatin US
4) Amarin: Icosapent Ethyl/Vascepa

Mochida uses "icosapentaenoic acid" in patent awarded 4-15-2014

Timing Tick/Tock...after the fate of Anchor...Mochida's taking on REDUCE-IT expences.

What could stop it?...

Nothing...GSK, Merck, AZN, and Pfizer dicked around too long...if you don't have the EPA you've got jack shit!
Diabetic franchise will be dominated by Mochida in the next 5 years. Japan's number one health priority is Metabolic Sydrome...responsible for 30% of ALL their Health Care.

Check Mate

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=EPA&s2=Metformin&OS=EPA+AND+Metformin&RS=EPA+AND+Metformin